0.906
Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
266.37%
63.74
|
17.40 | 14.81 | 8.52 | 25.71 |
|
21.91%
67.09
|
85.91 | 80.07 | 76.44 | 74.39 |
Benefits Costs and Expenses |
19.39%
75.26
|
93.37 | 84.90 | 57.31 | 73.72 |
Costs And Expenses |
19.39%
75.26
|
93.37 | 84.90 | 57.31 | 73.72 |
Operating Income/Loss |
95.12%
-3.345
|
-68.51 | -65.26 | -67.92 | -48.69 |
Income/Loss From Continuing Operations Before Tax |
84.84%
-11.52
|
-75.97 | -70.09 | -48.79 | -48.01 |
Income Tax Expense/Benefit |
357.14%
-0.018
|
0.007 | 2.355 | - | 0.008 |
Income/Loss From Continuing Operations After Tax |
84.86%
-11.50
|
-75.97 | -72.44 | -48.79 | -48.02 |
|
84.86%
-11.50
|
-75.97 | -72.44 | -48.79 | -48.02 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.77%
84.58
|
83.11 | 1.8945 | 82.04 | 81.22 |
Diluted Average Shares |
1.77%
84.58
|
83.11 | 1.8945 | 82.04 | 81.22 |
Basic Earnings Per Share |
84.62%
-0.14
|
-0.91 | -0.89 | -0.59 | -0.59 |
Diluted Earnings Per Share |
84.62%
-0.14
|
-0.91 | -0.89 | -0.59 | -0.59 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):